Bowhead Specialty (NYSE:BOW) Price Target Lowered to $43.00 at Keefe, Bruyette & Woods

Bowhead Specialty (NYSE:BOW - Free Report) had its price objective cut by Keefe, Bruyette & Woods from $44.00 to $43.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

Separately, JPMorgan Chase & Co. upped their target price on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $35.80.

Bowhead Specialty Trading Up 2.9 %

BOW stock traded up $1.12 during midday trading on Wednesday, reaching $39.12. 95,017 shares of the company's stock traded hands, compared to its average volume of 210,913. The company has a 50-day simple moving average of $35.76 and a two-hundred day simple moving average of $33.77. Bowhead Specialty has a 1-year low of $22.14 and a 1-year high of $42.29.

Bowhead Specialty (NYSE:BOW - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.07. The business had revenue of $184.77 million during the quarter, compared to the consensus estimate of $102.12 million. Analysts expect that Bowhead Specialty will post 1.36 EPS for the current fiscal year.

Insider Activity

In other news, Director Ava Schnidman bought 1,493 shares of the business's stock in a transaction on Friday, February 28th. The shares were purchased at an average price of $33.41 per share, for a total transaction of $49,881.13. Following the purchase, the director now owns 1,893 shares of the company's stock, valued at approximately $63,245.13. The trade was a 373.25 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in BOW. Gallatin Point Capital LLC acquired a new position in shares of Bowhead Specialty during the 4th quarter worth about $389,599,000. Victory Capital Management Inc. grew its stake in Bowhead Specialty by 129.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,508,003 shares of the company's stock valued at $53,564,000 after purchasing an additional 849,408 shares in the last quarter. Wasatch Advisors LP grew its stake in Bowhead Specialty by 125.3% in the fourth quarter. Wasatch Advisors LP now owns 812,901 shares of the company's stock valued at $28,874,000 after purchasing an additional 452,033 shares in the last quarter. Polar Capital Holdings Plc raised its stake in shares of Bowhead Specialty by 160.3% during the 4th quarter. Polar Capital Holdings Plc now owns 550,000 shares of the company's stock worth $19,536,000 after purchasing an additional 338,738 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its holdings in shares of Bowhead Specialty by 274.8% in the 4th quarter. Balyasny Asset Management L.P. now owns 314,684 shares of the company's stock valued at $11,178,000 after buying an additional 230,722 shares during the last quarter.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.